But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

This abated with antipsychotic medication so that she retracted her claims (with ... In any case, a diagnosis of ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...

Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.

Despite the challenges, many individuals with schizophrenia can lead fulfilling lives with the right treatment and support.

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant ...

The following search terms were used: ((((cognition OR cognitive OR neurocognitive OR neuropsychological OR neuropsychologic ...

Pharmacological therapy plays a vital role in treating this disease, where many mono and combination pharmacological ...